Quality of CurifyLabs’ Compounding System Solution Validated by Independent Laboratories

Quality of CurifyLabs’ Compounding System Solution Validated by Independent Laboratories: Ensuring Stability and Compliance of Pharmacy-Compounded Personalised Medicines

Achieving high quality is paramount for us, which is why we have demonstrated it by performing chemical and microbiological analysis of CuraBlend 1% prednisolone tablets by independent laboratories. With this we show our commitment to set new standards for compliance, safety, and precision in pharmaceutical compounding.

Manufacturing of the tablets was conducted under GMP-compliant conditions at two hospital pharmacy sites in Germany. Independent validation of our analytical methods and chemical content uniformity analyses were performed by Zentrallaboratorium Deutscher Apotheker (ZL) which confirmed the accuracy and reliability of our process. In addition to this, GMP level microbiological stability analyses that were performed by MeasurLabs further demonstrated the safety and integrity of each batch.

A 3-month stability study has now been completed, confirming the chemical stability, physical integrity, and microbiological safety of the products. Ongoing 6-month stability testing continues to assess long-term performance, reinforcing our commitment to high-quality, evidence-based pharmacy-compounded personalised medicines.

By adhering to rigorous validation protocols and independent verification by ZL and MeasurLabs, we want to ensure the highest standards of quality assurance and patient safety, driving innovation in personalized medicine manufacturing.

At CurifyLabs, we value our partnerships and want to thank ZL and Measurlabs for the smooth and professional collaboration thus far.